Clinical Trials Browser

Phase 4 × Not yet recruiting × Esophageal Squamous Cell Carcinoma × Clear all

NCT06388135 2024-04-29

Serplulimab Combined With Nab-paclitaxel and Cisplatin in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma

Phase 4 Not yet recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma